Botanix Pharmaceuticals Limited
BXPHF
$0.099
-$0.001-1.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.78M | -17.41M | -10.06M | -10.35M | -2.77M |
| Total Depreciation and Amortization | 367.00K | 359.40K | 364.30K | 374.60K | 21.10K |
| Total Amortization of Deferred Charges | 1.64M | 1.60M | -- | -- | -- |
| Total Other Non-Cash Items | 6.85M | 6.70M | -257.90K | -265.20K | 887.80K |
| Change in Net Operating Assets | -6.45M | -6.32M | -- | -- | 420.70K |
| Cash from Operations | -15.38M | -15.06M | -9.96M | -10.24M | -1.44M |
| Capital Expenditure | -62.70K | -61.40K | -29.50K | -30.30K | -25.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | -248.70K | -255.80K | -1.04M |
| Cash from Investing | -62.70K | -61.40K | -278.20K | -286.10K | -1.06M |
| Total Debt Issued | 14.20M | 14.20M | -- | -- | -- |
| Total Debt Repaid | -65.50K | -65.50K | -30.80K | -30.80K | -- |
| Issuance of Common Stock | 20.00M | 20.00M | 231.00K | 231.00K | 36.26M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.65M | -1.65M | -- | -- | -2.09M |
| Cash from Financing | 20.81M | 20.37M | 130.50K | 134.10K | 22.52M |
| Foreign Exchange rate Adjustments | -66.60K | -65.20K | 46.90K | 48.20K | 80.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.29M | 5.18M | -10.06M | -10.34M | 20.10M |